Picture of Biovica International AB logo

BIOVIC B — Biovica International AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Biovica International Says Observational Trial With Divitum TKa Started

April 12 (Reuters) - Biovica International AB
 BIOVICb.ST :
    * OBSERVATIONAL TRIAL WITH DIVITUM TKA STARTED AT MAYO
CLINIC,
FLORIDA TO VALIDATE UTILITY OF DIVITUM TKA AS AN EFFECTIVE TOOL
FOR DISEASE MONITORING


Further company coverage:  BIOVICb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on Biovica International AB

See all news